Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.
暂无分享,去创建一个
M. Winker | T. Tsuruo | R. Ozols | G. Batist | T. Hamilton | R. Young | T. C. Hamilton | K. Louie | B. Behrens | K. Grotzinger | W. Mckoy | K. G. Louie
[1] M. Winker,et al. Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. , 1985, Cancer research.
[2] R. Ozols,et al. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. , 1984, Cancer research.
[3] R C Young,et al. Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches. , 1984, Seminars in oncology.
[4] R. Ozols,et al. Reversal of adriamycin resistance by verapamil in human ovarian cancer. , 1984, Science.
[5] S. Somfai-Relle,et al. Glutathione-conferred resistance to antineoplastics: approaches toward its reduction. , 1984, Cancer treatment reviews.
[6] T. Tsuruo,et al. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers. , 1983, Cancer research.
[7] J. Lautenberger,et al. Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells , 1982, Nature.
[8] W. Jakoby,et al. [27] Glutathione S-transferases (rat and human) , 1981 .
[9] J. Willson,et al. Cloning of Human Ovarian Cancer Cells in Soft Agar from Malignant Effusions and Peritoneal Washings , 1980 .
[10] W. Valentine,et al. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.
[11] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.